U.S. pharmaceutical company Moderna is interested in investing in production facilities in Germany, with an eye on plants that its German rival BioNTech plans to close, CEO Stephane Bancel told the German business daily Handelsblatt on Wednesday.
BERLIN, June 17 (Reuters) – U.S. pharmaceutical company Moderna (MRNA.O), opens new tab is interested in investing in production facilities in Germany, with an eye on plants that its German rival BioNTech plans to close, CEO Stephane Bancel t… [303 chars]
Source: Reuters | Published: 2026-06-17T06:38:57Z
Credit: Reuters
